Isotretinoin in Thick-Skin Rhinoplasty: A Review
- PMID: 40291370
- PMCID: PMC12020492
- DOI: 10.1055/s-0044-1801319
Isotretinoin in Thick-Skin Rhinoplasty: A Review
Abstract
Introduction Thick-skinned patients are prevalent in the general population worldwide and represent a challenge for the rhinoplasty surgeon. The use of oral isotretinoin before and/or after surgery is a possible adjuvant treatment that can facilitate intraoperative management and improve results in the postoperative stages; however, there are still questions about its effects in the long-term. Objective To evaluate the advantages and best practices for orally administrated isotretinoin in thick-skin rhinoplasty based on the current literature. Methods An advanced search was conducted until August 31st, 2023, on the PubMed, Cochrane Library, ClinicalTrials.gov, Embase, and LILACS databases with the keywords rhinoplasty and isotretinoin . Sixteen articles were reviewed and 4 met the inclusion criteria, with a total of 371 patients. Meta-analysis of the data collected was not possible due to heterogeneity among papers. Conclusion Isotretinoin can be a safe drug, and its use in rhinoplasty varies widely, although all studies reported a low-dose oral regime for up to 6 months. The medication use is well-established in thick-skin rhinoplasty. Small doses after the procedure can improve patient satisfaction and the quality and thickness of the skin in the first 6 months of postsurgery. After 6 months, studies with a control group did not show a significant difference in patient satisfaction rates. A strong framework and specific surgical maneuvers may be more important than isotretinoin for better outcomes in thick-skin rhinoplasty.
Keywords: isotretinoin; rhinoplasty; thick skin; thick-skin rhinoplasty.
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit ( https://creativecommons.org/licenses/by/4.0/ ).
Conflict of interest statement
Conflict of Interests The authors have no conflict of interests to declare.
Figures
References
-
- Ishii L E, Tollefson T T, Basura G Jet al.Clinical practice guideline: improving nasal form and function after rhinoplasty Otolaryngol Head Neck Surg 2017156(2_suppl)S1–S30. - PubMed
-
- Fichman M, Piedra Buena I T.Rhinoplasty In: StatPearls . [Internet] Treasure Island (FL): StatPearls Publishing; June 12, 2023. Available at:https://www.ncbi.nlm.nih.gov/books/NBK558970/. It was Accessed November 30, 2023.
-
- Yahyavi S, Jahandideh H, Izadi M, Paknejad H, Kordbache N, Taherzade S. Analysis of the Effects of Isotretinoin on Rhinoplasty Patients. Aesthet Surg J. 2020;40(12):NP657–NP665. - PubMed
-
- Cobo R, Camacho J G, Orrego J. Integrated management of the thick-skinned rhinoplasty patient. Facial Plast Surg. 2018;34(01):3–8. - PubMed
-
- Kosins A M, Obagi Z E. Managing the difficult soft tissue envelope in facial and rhinoplasty surgery. Aesthet Surg J. 2017;37(02):143–157. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
